19-36055113-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001083961.2(WDR62):​c.142C>T​(p.Leu48Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,607,278 control chromosomes in the GnomAD database, including 153 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0077 ( 6 hom., cov: 33)
Exomes 𝑓: 0.014 ( 147 hom. )

Consequence

WDR62
NM_001083961.2 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.382

Publications

8 publications found
Variant links:
Genes affected
WDR62 (HGNC:24502): (WD repeat domain 62) This gene is proposed to play a role in cerebral cortical development. Mutations in this gene have been associated with microencephaly, cortical malformations, and cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]
WDR62 Gene-Disease associations (from GenCC):
  • microcephaly 2, primary, autosomal recessive, with or without cortical malformations
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P, ClinGen
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0042237043).
BP6
Variant 19-36055113-C-T is Benign according to our data. Variant chr19-36055113-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93535.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00772 (1176/152240) while in subpopulation NFE AF = 0.0137 (932/67994). AF 95% confidence interval is 0.013. There are 6 homozygotes in GnomAd4. There are 520 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR62NM_001083961.2 linkc.142C>T p.Leu48Phe missense_variant Exon 1 of 32 ENST00000401500.7 NP_001077430.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR62ENST00000401500.7 linkc.142C>T p.Leu48Phe missense_variant Exon 1 of 32 1 NM_001083961.2 ENSP00000384792.1

Frequencies

GnomAD3 genomes
AF:
0.00773
AC:
1176
AN:
152122
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00307
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0137
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00715
AC:
1638
AN:
229006
AF XY:
0.00735
show subpopulations
Gnomad AFR exome
AF:
0.00274
Gnomad AMR exome
AF:
0.00205
Gnomad ASJ exome
AF:
0.00156
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00232
Gnomad NFE exome
AF:
0.0130
Gnomad OTH exome
AF:
0.00657
GnomAD4 exome
AF:
0.0135
AC:
19664
AN:
1455038
Hom.:
147
Cov.:
32
AF XY:
0.0132
AC XY:
9542
AN XY:
723542
show subpopulations
African (AFR)
AF:
0.00201
AC:
67
AN:
33324
American (AMR)
AF:
0.00232
AC:
103
AN:
44324
Ashkenazi Jewish (ASJ)
AF:
0.00212
AC:
55
AN:
26002
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39370
South Asian (SAS)
AF:
0.00409
AC:
349
AN:
85398
European-Finnish (FIN)
AF:
0.00267
AC:
136
AN:
50922
Middle Eastern (MID)
AF:
0.000870
AC:
5
AN:
5750
European-Non Finnish (NFE)
AF:
0.0166
AC:
18387
AN:
1109898
Other (OTH)
AF:
0.00936
AC:
562
AN:
60050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1138
2275
3413
4550
5688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00772
AC:
1176
AN:
152240
Hom.:
6
Cov.:
33
AF XY:
0.00699
AC XY:
520
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.00306
AC:
127
AN:
41554
American (AMR)
AF:
0.00379
AC:
58
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4822
European-Finnish (FIN)
AF:
0.00264
AC:
28
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0137
AC:
932
AN:
67994
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
63
125
188
250
313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
27
Bravo
AF:
0.00789
TwinsUK
AF:
0.0119
AC:
44
ALSPAC
AF:
0.0166
AC:
64
ESP6500AA
AF:
0.00326
AC:
13
ESP6500EA
AF:
0.0104
AC:
83
ExAC
AF:
0.00645
AC:
770
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WDR62: BP4, BS1, BS2 -

Jan 11, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:4
Aug 09, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 23, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Microcephaly 2, primary, autosomal recessive, with or without cortical malformations Benign:4
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.0068
.;T;.
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.63
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.54
T;T;T
MetaRNN
Benign
0.0042
T;T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
1.9
L;L;.
PhyloP100
0.38
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.15
Sift
Benign
0.34
T;T;T
Sift4G
Benign
0.72
T;T;T
Polyphen
0.0030
B;B;.
Vest4
0.17
MVP
0.61
MPC
0.24
ClinPred
0.0078
T
GERP RS
4.3
PromoterAI
0.067
Neutral
Varity_R
0.076
gMVP
0.29
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62109744; hg19: chr19-36546015; COSMIC: COSV105820158; API